Patent details
LUC00269 Product Name: Roxadustat
Basic Information
- Publication number:
- LUC00269
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP181896077
- Legal Status:
- Pending & Published
- Application number:
- LUC00269
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/21/1574
- Marketing Authorization Type:
- Marketing Authorization Date:
- 19/08/2021
- Marketing Authorization Status:
- Claimed
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 15/06/2022
- First Marketing Authorization date:
- 19/08/2021
- Grant date:
- Activation date:
- Publication date:
- 15/06/2022
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 19/08/2036
- SPC Extension Expiration:
- 19/08/2036
- Rejection date:
- Withdrawal date:
Owner
- From:
- 15/06/2022
- Name:
- Fibrogen, Inc.
- Address:
- 409 Illinois Street, San Francisco, CA 94158, United States (US)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 15/06/2022
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2022/08
- Publication date:
- 01/07/2022
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
Other
- Note:
- (03/02/2023) Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant
| Filing date | Document type | Number of pages |
|---|---|---|
| 15/06/2022 | Application Form | 5 |
| 15/06/2022 | Marketing authorization | 3 |
| 15/06/2022 | MA publication | 2 |
| 15/06/2022 | Summary of the product caracteristics | 53 |
| 15/06/2022 | General Document | 47 |
| 15/06/2022 | Publication | 1 |
| 15/06/2022 | Outgoing Correspondence | 1 |
| 03/02/2023 | Incoming Correspondence (Post) | 1 |
| 03/02/2023 | Outgoing Correspondence | 1 |